Trump Endorsed a Risky Antidepressant for Veterans. Lawmakers Want to Know if His Mar-a-Lago Pals Had a Stake in the Drugmaker

I think Isaac Arnsdorf did an excellent job highlighting some concerning aspects of Spravato’s approval process within the FDA and also what has happened since it hit the market. His piece is here.

This entry was posted in Miscellaneous. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *